Platelet transfusion study for very preterm babies
Part of Blood & lymphatic, Genetic & congenital, Heart & circulation clinical trials.
This study looks at the best way to decide when to give platelet transfusions to very premature babies. It aims to help prevent bleeding while avoiding unnecessary transfusions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born between 23 and 27 weeks of pregnancy.
- Your baby is less than 2 days old (48 hours).
- Doctors are not planning to stop active treatment and focus only on comfort care.
- Your baby does not have a known bleeding disorder or a condition that destroys platelets.
- Your baby has not already received a platelet transfusion.
- Your baby received a vitamin K shot after birth.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different amounts of platelet transfusions to see which is safer and more effective for premature babies with very low platelet counts. Platelets are tiny cells in the blood that help stop bleeding, so this treatment may reduce the risk of serious bleeding in the brain.
This study looks at how giving platelets to patients with low platelet counts affects the health of small blood vessels. It aims to see if platelet transfusions help improve blood flow and vessel function in critically ill patients.
This study tests a machine called ROTEM Sigma that measures how well your blood clots, specifically in pregnant women who have or may have low platelet counts (cells that help blood clot). The goal is to help doctors better predict bleeding problems during or after delivery.
This study looks at platelet transfusions—how they’re used and whether platelets function well—for people with blood cancers who have low platelet counts. It may help improve transfusion care for people who need platelet support.
This study is testing a new way to use whole blood transfusions to treat severe malaria in young children. It might help children with very low platelet counts and low hemoglobin recover better.
This trial looks at how to estimate bleeding risk in newborns who are very premature and have a low platelet count. The goal is to guide safer care by better identifying which babies may be at higher risk of bleeding.
Hear when a new Thrombocytopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.